A low-energy total diet replacement programme demonstrates a favourable safety profile and improves liver disease severity in non-alcoholic steatohepatitis
<p><strong>Objective:</strong> Low-energy diets are used to treat obesity and diabetes, but there are fears that they may worsen liver disease in patients with nonalcoholic steatohepatitis (NASH) and significant-to-advanced fibrosis.</p> <p><strong>Methods:</s...
Main Authors: | Koutoukidis, D, Mozes, F, Jebb, S, Tomlinson, J, Pavlides, M, Saffioti, F, Huntriss, R, Aveyard, P, Cobbold, J |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Wiley
2023
|
Similar Items
-
Association of weight changes with changes in histological features and blood markers in non-alcoholic steatohepatitis
by: Koutoukidis, D, et al.
Published: (2021) -
Association of changes in histological severity of non-alcoholic steatohepatitis and changes in patient-reported quality of life
by: Heath, L, et al.
Published: (2022) -
Association of changes in histologic severity of nonalcoholic steatohepatitis and changes in patient‐reported quality of life
by: Laura Heath, et al.
Published: (2022-10-01) -
What proportion of people have a follow-up biopsy in randomized trials of treatments for non-alcoholic steatohepatitis?: A systematic review and meta-analysis
by: Koutoukidis, DA, et al.
Published: (2021) -
Heterogeneity in the uptake, attendance and outcomes in a clinical trial of a total diet replacement weight loss programme
by: Astbury, N, et al.
Published: (2020)